miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma.

MLA

Zhang, Manchao, et al. “MiR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma.” Molecular Cancer Therapeutics, vol. 14, no. 10, Oct. 2015, pp. 2313–20. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-14-1071.

APA

Zhang, M., Piao, L., Datta, J., Lang, J. C., Xie, X., Teknos, T. N., Mapp, A. K., & Pan, Q. (2015). miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics, 14(10), 2313–2320. https://doi.org/10.1158/1535-7163.MCT-14-1071

Chicago

Zhang, Manchao, Longzhu Piao, Jharna Datta, James C Lang, Xiujie Xie, Theodoros N Teknos, Anna K Mapp, and Quintin Pan. 2015. “MiR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma.” Molecular Cancer Therapeutics 14 (10): 2313–20. doi:10.1158/1535-7163.MCT-14-1071.